Provexis plc

Research Provexis plc (PXS.L) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025GBP 1.29M-GBP 452.72K-GBP 340.83K41.2%n/aGBP 708.09Kn/aGBP 1.30M
FY2024GBP 801.96K-GBP 586.24K-GBP 191.50K35.4%0GBP 189.36Kn/aGBP 724.34K
FY2023GBP 389.92K-GBP 385.24K-GBP 520.74K75.5%0GBP 379.12Kn/aGBP 1.19M
FY2022GBP 426.17K-GBP 224.25K-GBP 213.62K89.2%0GBP 863.87Kn/aGBP 1.50M

About Provexis plc

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product.

Related stock research

Other Healthcare stocks

Frequently asked questions

What does Provexis plc do?

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through e-commerce website and distributors.